AT512200T - Hydrogele with hydrogen bridge bondings - Google Patents

Hydrogele with hydrogen bridge bondings

Info

Publication number
AT512200T
AT512200T AT06733083T AT06733083T AT512200T AT 512200 T AT512200 T AT 512200T AT 06733083 T AT06733083 T AT 06733083T AT 06733083 T AT06733083 T AT 06733083T AT 512200 T AT512200 T AT 512200T
Authority
AT
Austria
Prior art keywords
hydrogele
bondings
hydrogen bridge
bridge
hydrogen
Prior art date
Application number
AT06733083T
Other languages
German (de)
Inventor
Gemert Gaby Maria Hoorne-Van
Anton Bosman
Egbert Meijer
Henricus Janssen
Original Assignee
Suprapolix Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to EP05103763 priority Critical
Priority to US67964905P priority
Application filed by Suprapolix Bv filed Critical Suprapolix Bv
Priority to PCT/NL2006/050106 priority patent/WO2006118460A1/en
Publication of AT512200T publication Critical patent/AT512200T/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K8/00—Cosmetics or similar toilet preparations
    • A61K8/18—Cosmetics or similar toilet preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toilet preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6903—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being semi-solid, e.g. an ointment, a gel, a hydrogel or a solidifying gel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K8/00—Cosmetics or similar toilet preparations
    • A61K8/02—Cosmetics or similar toilet preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/042—Gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K8/00—Cosmetics or similar toilet preparations
    • A61K8/18—Cosmetics or similar toilet preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toilet preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/736—Chitin; Chitosan; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K8/00—Cosmetics or similar toilet preparations
    • A61K8/18—Cosmetics or similar toilet preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toilet preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toilet preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K8/00—Cosmetics or similar toilet preparations
    • A61K8/18—Cosmetics or similar toilet preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toilet preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toilet preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86—Polyethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K8/00—Cosmetics or similar toilet preparations
    • A61K8/18—Cosmetics or similar toilet preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toilet preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/90—Block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILET PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L101/00—Compositions of unspecified macromolecular compounds
    • C08L101/12—Compositions of unspecified macromolecular compounds characterised by physical features, e.g. anisotropy, viscosity or electrical conductivity
    • C08L101/14—Compositions of unspecified macromolecular compounds characterised by physical features, e.g. anisotropy, viscosity or electrical conductivity the macromolecular compounds being water soluble or water swellable, e.g. aqueous gels
AT06733083T 2005-05-04 2006-05-03 Hydrogele with hydrogen bridge bondings AT512200T (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP05103763 2005-05-04
US67964905P true 2005-05-11 2005-05-11
PCT/NL2006/050106 WO2006118460A1 (en) 2005-05-04 2006-05-03 Hydrogen bonded hydrogels

Publications (1)

Publication Number Publication Date
AT512200T true AT512200T (en) 2011-06-15

Family

ID=35708383

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06733083T AT512200T (en) 2005-05-04 2006-05-03 Hydrogele with hydrogen bridge bondings

Country Status (6)

Country Link
US (1) US8246990B2 (en)
EP (1) EP1907482B1 (en)
JP (2) JP2008540725A (en)
AT (1) AT512200T (en)
ES (1) ES2367583T3 (en)
WO (1) WO2006118460A1 (en)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6066325A (en) 1996-08-27 2000-05-23 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
US8303981B2 (en) 1996-08-27 2012-11-06 Baxter International Inc. Fragmented polymeric compositions and methods for their use
US8603511B2 (en) 1996-08-27 2013-12-10 Baxter International, Inc. Fragmented polymeric compositions and methods for their use
US7435425B2 (en) 2001-07-17 2008-10-14 Baxter International, Inc. Dry hemostatic compositions and methods for their preparation
US8834864B2 (en) 2003-06-05 2014-09-16 Baxter International Inc. Methods for repairing and regenerating human dura mater
US7927626B2 (en) 2003-08-07 2011-04-19 Ethicon, Inc. Process of making flowable hemostatic compositions and devices containing such compositions
EP1687378B1 (en) 2003-11-04 2014-01-08 SupraPolix B.V. Preparation of supramolecular polymers containing quadruple hydrogen bonding units in the polymer backbone
US8268952B2 (en) 2004-07-12 2012-09-18 Suprapolix B.V. Supramolecular ionomers
JP2008540725A (en) 2005-05-04 2008-11-20 スープラポリックス ビー．ブイ． Hydrogen bonded hydrogel
US8883188B2 (en) 2005-05-04 2014-11-11 Suprapolix B.V. Modular bioresorbable or biomedical, biologically active supramolecular materials
JP5231401B2 (en) 2006-05-31 2013-07-10 バクスター・インターナショナル・インコーポレイテッドＢａｘｔｅｒ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｎｃｏｒｐ０Ｒａｔｅｄ Method of guided cell ingrowth and controlled tissue regeneration in spinal surgery
TWI436793B (en) * 2006-08-02 2014-05-11 Baxter Int Rapidly acting dry sealant and methods for use and manufacture
US20100076147A1 (en) 2006-11-20 2010-03-25 Suprapolix B.V. Supramolecular polymers from low-melting, easily processable building blocks
ES2369189T3 (en) 2007-03-23 2011-11-28 Suprapolix B.V. Strongly reversible hydrogels.
US8628789B2 (en) 2007-03-23 2014-01-14 Suprapolix, B.V. Strong reversible hydrogels
US8790698B2 (en) 2007-10-30 2014-07-29 Baxter International Inc. Use of a regenerative biofunctional collagen biomatrix for treating visceral or parietal defects
US8754213B2 (en) 2008-07-04 2014-06-17 Suprapolix B.V. High flow supramolecular compounds
FR2933295B1 (en) 2008-07-04 2010-07-30 Oreal Cosmetic or dermatological composition comprising a compound capable of establishing hydrogen bonds, and cosmetic processing method
US9039783B2 (en) 2009-05-18 2015-05-26 Baxter International, Inc. Method for the improvement of mesh implant biocompatibility
JP5719355B2 (en) 2009-06-16 2015-05-20 バクスター・インターナショナル・インコーポレイテッドＢａｘｔｅｒ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｎｃｏｒｐ０Ｒａｔｅｄ Hemostatic sponge
CA2784432C (en) 2009-12-16 2019-01-15 Baxter Healthcare S.A. Hemostatic sponge
FR2954130B1 (en) * 2009-12-18 2012-02-24 Oreal Cosmetic composition comprising a supramolecular compound capable of establishing hydrogen bonds, and a particular additional ingredient
FR2954132B1 (en) * 2009-12-18 2015-03-13 Oreal Cosmetic composition comprising a supramolecular compound capable of establishing hydrogen bonds and an apolar pasty fatty body
FR2954131B1 (en) * 2009-12-18 2016-02-19 Oreal Cosmetic composition comprising a supramolecular compound capable of establishing hydrogen bonds, and a particular oil
DK2555804T3 (en) 2010-04-07 2015-08-03 Baxter Int hemostatic sponge
BR112012030457A2 (en) 2010-06-01 2017-06-20 Baxter Healthcare Sa process for making a dry and stable hesostatic composition, method for delivering a hemostatic composition to a target site and providing a ready-to-use hemostatic composition, finished finished container, and kit for administering a hemostatic composition
KR101957625B1 (en) 2010-06-01 2019-03-12 백스터 인터내셔널 인코포레이티드 Process for making dry and stable hemostatic compositions
BR112012030455A2 (en) 2010-06-01 2016-08-09 Baxter Healthcare Sa process for making a dry and stable hesostatic composition, method for dispensing a hemostatic composition to a target site on a patient's body, final finished container, method for providing a ready-to-use hemostatic composition, and kit for administering a hemostatic composition
EP2450394B1 (en) 2010-11-05 2017-06-07 SupraPolix B.V. A process for the preparation of a supramolecular polymer
EP2665783A2 (en) 2011-01-19 2013-11-27 President and Fellows of Harvard College Slippery liquid-infused porous surfaces and biological applications thereof
CA2825008A1 (en) 2011-01-19 2012-07-26 President And Fellows Of Harvard College Slippery surfaces with high pressure stability, optical transparency, and self-healing characteristics
WO2012168392A1 (en) * 2011-06-07 2012-12-13 Technische Universiteit Eindhoven Hydrogelator with shape-memory properties
JP6195568B2 (en) 2011-10-11 2017-09-13 バクスター・インターナショナル・インコーポレイテッドＢａｘｔｅｒ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｎｃｏｒｐ０Ｒａｔｅｄ Hemostatic composition
US20130096063A1 (en) 2011-10-11 2013-04-18 Baxter Healthcare S.A. Hemostatic compositions
WO2013060770A1 (en) 2011-10-27 2013-05-02 Baxter International Inc. Hemostatic compositions
CA2878683A1 (en) * 2012-07-12 2014-01-16 President And Fellows Of Harvard College Slippery self-lubricating polymer surfaces
WO2014012079A1 (en) 2012-07-13 2014-01-16 President And Fellows Of Harvard College Multifunctional repellent materials
WO2014012039A1 (en) 2012-07-13 2014-01-16 President And Fellows Of Harvard College Slippery liquid-infused porous surfaces having improved stability
EP2969258A4 (en) 2013-03-13 2016-11-30 Harvard College Solidifiable composition for preparation of liquid-infused slippery surfaces and methods of applying
EP3174524A1 (en) 2014-07-28 2017-06-07 SupraPolix B.V. Durable hydrogen bonded hydrogels
JP6496967B2 (en) * 2014-11-25 2019-04-10 花王株式会社 Polymer for cosmetics
EP3277745A4 (en) * 2015-04-02 2018-12-12 The Regents of The University of Michigan Self-integrating hydrogels and methods for making the same

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3378250D1 (en) * 1982-04-22 1988-11-24 Ici Plc Continuous release formulations
KR0148704B1 (en) * 1994-01-10 1998-08-17 김상응 Biodegradable polymer as drug delivery
US5883211A (en) * 1996-01-19 1999-03-16 Aclara Biosciences, Inc. Thermoreversible hydrogels comprising linear copolymers and their use in electrophoresis
JPH09235213A (en) * 1996-02-29 1997-09-09 Kanebo Ltd Gelatinous hair-dressing agent
NL1004192C2 (en) * 1996-10-04 1998-04-07 Dsm Nv Supramolecular polymer.
CA2299393A1 (en) 1997-08-08 1999-02-18 Sung Wan Kim Injectable biodegradable block copolymer gels for use in drug delivery
ES2245805T3 (en) * 1997-10-03 2006-01-16 Galenica Pharmaceuticals, Inc. Polisacarids forming iminas, preparation of the same and the use of the same as assistants of immuno stimulants.
US6818018B1 (en) * 1998-08-14 2004-11-16 Incept Llc In situ polymerizable hydrogels
JP2002167308A (en) * 2000-12-01 2002-06-11 Kanebo Ltd Gel type hairdressing agent
EP1213309A1 (en) 2000-12-05 2002-06-12 Huntsman International Llc Supramolecular polymer forming polymer
FR2825628B1 (en) * 2001-06-07 2004-03-19 Oreal Cosmetic composition comprising a polymer comprising linking groups each capable of forming at least three bonds h
US6972304B2 (en) * 2001-09-07 2005-12-06 Xerox Corporation Aqueous ink compositions
GB0124967D0 (en) * 2001-10-17 2001-12-05 Unilever Plc Cosmetic and personal care compositions
DE60313606T2 (en) * 2002-05-27 2008-01-03 Huntsman International Llc, Salt Lake City Expanded supramolecular polymers
US6803447B2 (en) * 2002-08-16 2004-10-12 Eutechpark Mmp1.28 Preparation of supramolecular polymers by copolymerization of monomers containing quadruple hydrogen bonding units with regular monomers
EP1687378B1 (en) * 2003-11-04 2014-01-08 SupraPolix B.V. Preparation of supramolecular polymers containing quadruple hydrogen bonding units in the polymer backbone
JP2008540725A (en) 2005-05-04 2008-11-20 スープラポリックス ビー．ブイ． Hydrogen bonded hydrogel

Also Published As

Publication number Publication date
EP1907482A1 (en) 2008-04-09
JP5607127B2 (en) 2014-10-15
EP1907482B1 (en) 2011-06-08
WO2006118460A1 (en) 2006-11-09
US20090004274A1 (en) 2009-01-01
ES2367583T5 (en) 2011-11-04
JP2013047346A (en) 2013-03-07
JP2008540725A (en) 2008-11-20
ES2367583T3 (en) 2011-11-10
US8246990B2 (en) 2012-08-21

Similar Documents

Publication Publication Date Title
DK1888550T3 (en) Apoptosepromotorer
DK1846064T3 (en) Indföringsanordning
DK1893196T3 (en) Diarylhydantoin connection
DK1869049T3 (en) Imidazopyridazinforbindelser
DK1928882T3 (en) (S) -N-methylnaltrexone
DK1893251T3 (en) Aspirationsstyring
DK1909625T3 (en) Törreapparat
DE602006017614D1 (en) Anastomoseverbunddichtung
AT408603T (en) pyrazolylcarboxanilides
AT446040T (en) Handstaubsauger
DE602006007822D1 (en) nrate
AT523504T (en) 1-thio-D-GLUCITOLDERIVATE
DE502006008299D1 (en) Nickness lanzette
DE602006020094D1 (en) Ösennahtanker
AT416818T (en) Textile-based electrode
AT552163T (en) Straddle-VEHICLE
DE602006015986D1 (en) Instant-messaging-installation-bzw. -serverprotokoll
AT527526T (en) Photonenzählvorrichtung
DE602006018394D1 (en) Hybridcopolymere
DE602006015785D1 (en) L-DIMENSION-scatterometry
DE502006003957D1 (en) NANO-thermoelectrics
DE602005020856D1 (en) Unterhose
AT539711T (en) Hüftpfannenpositionierung
DK1844813T3 (en) Iontoforeseapparat
AT485852T (en) Oberflächeninjizierungsvorrichtung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties